News archive.
Earlier AI news and analysis, kept for reference. Current coverage lives in News & Analysis.
India deploys Ebola screening portal for all international arrivals
The Air Suvidha 2.0 portal requires passengers to submit health declarations 24 hours before landing in India. Real-time data sharing with health authorities aims to catch at-risk travellers amid the DRC outbreak.
India eyes $8B assistive tech market by 2030, needs national policy
India's addressable market for assistive technology could reach Rs 75,000-95,000 crore by 2030 with the right policy framework, experts say. A new white paper calls for coordinated governance to unlock innovation and inclusion.
80% of doctors use AI. Your IT team hasn't caught up.
Physicians are adopting AI faster than health systems can govern it, creating security gaps and shadow-IT risks. Here's what administrators should do now.
Lilly and Astellas bid for Sangamo assets in gene-therapy auction
Eli Lilly and Astellas are lead bidders on bankrupt Sangamo's gene-editing portfolio. Separately, VCs back a Beam competitor with $230M and Merck KGaA signs a build-to-buy deal.
Psychedelics biotech win validates entire field for Wall Street
Definium Therapeutics' clinical trial success is lifting investor sentiment across psychedelics startups, even for direct competitors. Analysts say positive data from one player validates the sector's science.
$115M bet on RQ Bio's flu antibody to outlast multiple strains
$115 million rounds the financing for RQ Bio's antibody candidate, which the startup claims provides durable protection across flu variants. What makes it different from seasonal vaccines.
Abbott's MiniMed Instinct sensor hits Europe as overseas sales fuel growth
MiniMed launched the Abbott-made Instinct glucose sensor in Europe. Overseas markets account for 70% of the company's annual sales, making the expansion strategically significant.
HHS fast-tracks early drug trials in U.S. to counter China's advantage
The Department of Health and Human Services is streamlining regulations to get biotech companies to run Phase 1 and Phase 2 trials domestically instead of abroad. The shift aims to reclaim lost ground in clinical research competition.
FDA clears Whoop blood pressure feature after design changes
Whoop resolved a federal warning letter by modifying how its wearable presents blood pressure insights. The company now classifies the feature as wellness, not medical diagnosis.
$50B rural health fund is pushing hospitals to downsize inpatient beds
$50 billion in federal funding is steering rural hospitals toward proven cost cuts like reducing inpatient capacity rather than experimental approaches. Here's what hospitals are actually choosing.
Democrats demand CMS release data on Medicare AI prior authorization delays
Lawmakers are pressing the Centers for Medicare and Medicaid Services for transparency on WISeR, an AI system flagged for slowing approvals to beneficiaries. The letter marks escalating concern over care delays.
Florida Sues CVS Pharmacy Over Anticompetitive Drug Pricing Practices
Florida's attorney general has opened an investigation into CVS and its pharmacy benefit manager unit for allegedly driving up drug costs through anticompetitive conduct. The move reflects a widening state-level push against PBM practices.